RespireRx Pharmaceuticals Inc (fka RSPI)

[DewDiligence]

I suspect it is already a done deal as well, but can you explain why investors buying shares would likely favor mgmt's proposal?

The logic could not be any simpler: If the buyers in question thought management’s proposal was going to work to their disadvantage, they would not be buying shares in the first place.

To reiterate, the 17-day waiting period between the SEC PRE14A filing and the record date for the shareholder vote works strongly to management’s advantage by cleansing the shareholder base of holders with views contrary to those of management. Despite the lopsided preference on this message board for a No vote, I predict that Yes will carry the day by a wide margin. Regards, Dew